Recent progress in sodium channel modulators for pain

被引：138
作者：
Bagal, Sharan K. [1 ]
Chapman, Mark L. [2 ]
Marron, Brian E. [3 ]
Prime, Rebecca [4 ]
Storer, R. Ian [1 ]
Swain, Nigel A. [1 ]
机构：
[1] Pfizer Neusentis, Worldwide Med Chem, Cambridge CB21 6GS, England
[2] Pfizer Neusentis, Electrophysiology, Durham, NC USA
[3] Pfizer Neusentis, Chemistry, Durham, NC USA
[4] Pfizer Neusentis, Electrophysiology, Cambridge CB21 6GS, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 16期
关键词：
Voltage-gated sodium channels; Electrophysiology screening; Sodium channel toxins; Sodium channel structure; Sodium channel drugs; OF-FUNCTION MUTATIONS; HUWENTOXIN-IV; CRYSTAL-STRUCTURE; DRUG DISCOVERY; NA+ CURRENT; PROTX-II; INHIBITOR; TETRODOTOXIN; MECHANISMS; POTENT;
D O I：
10.1016/j.bmcl.2014.06.038
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Voltage-gated sodium channels (Na(v)s) are an important family of transmembrane ion channel proteins and Na-v drug discovery is an exciting field. Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda (R), Synchropatch (R) and Qube (R). Moreover, emerging clinical data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biology pave the way for a future of fruitful prospective Nav drug discovery. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码：3690 / 3699
页数：10
相关论文
共 88 条
  • [11] Structural Determinants of Drugs Acting on the Nav1.8 Channel
    Browne, Liam E.
    Blaney, Frank E.
    Yusaf, Shahnaz P.
    Clare, Jeff J.
    Wray, Dennis
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (16) : 10523 - 10536
  • [12] Sodium Channel Inhibitor Drug Discovery Using Automated High Throughput Electrophysiology Platforms
    Castle, Neil
    Printzenhoff, David
    Zellmer, Shannon
    Antonio, Brett
    Wickenden, Alan
    Silvia, Christopher
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2009, 12 (01) : 107 - 122
  • [13] Molecular mechanisms of neurotoxin action on voltage-gated sodium channels
    Cestèle, S
    Catterall, WA
    [J]. BIOCHIMIE, 2000, 82 (9-10) : 883 - 892
  • [14] Clare JJ, 2010, DISCOV MED, V9, P253
  • [15] Corkey B. K., 2013, [No title captured], Patent No. [US 20130005706, 20130005706]
  • [16] An SCN9A channelopathy causes congenital inability to experience pain
    Cox, James J.
    Reimann, Frank
    Nicholas, Adeline K.
    Thornton, Gemma
    Roberts, Emma
    Springell, Kelly
    Karbani, Gulshan
    Jafri, Hussain
    Mannan, Jovaria
    Raashid, Yasmin
    Al-Gazali, Lihadh
    Hamamy, Henan
    Valente, Enza Maria
    Gorman, Shaun
    Williams, Richard
    McHale, Duncan P.
    Wood, John N.
    Gribble, Fiona M.
    Woods, C. Geoffrey
    [J]. NATURE, 2006, 444 (7121) : 894 - 898
  • [17] The roles of sodium channels in nociception: Implications for mechanisms of pain
    Cummins, Theodore R.
    Sheets, Patrick L.
    Waxman, Stephen G.
    [J]. PAIN, 2007, 131 (03) : 243 - 257
  • [18] Dehnhardt C. M., 2014, International Patent, Patent No. [WO 2014008458, 2014008458, WO 2014008458 A2]
  • [19] Two tetrodotoxin-resistant sodium channels in human dorsal root ganglion neurons
    Dib-Hajj, SD
    Tyrrell, L
    Cummins, TR
    Black, JA
    Wood, PM
    Waxman, SG
    [J]. FEBS LETTERS, 1999, 462 (1-2) : 117 - 120
  • [20] Sodium Channels in Normal and Pathological Pain
    Dib-Hajj, Sulayman D.
    Cummins, Theodore R.
    Black, Joel A.
    Waxman, Stephen G.
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, VOL 33, 2010, 33 : 325 - 347
123456789